HRT raises risk of rare, treatable breast cancerBMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7199.1645b (Published 19 June 1999) Cite this as: BMJ 1999;318:1645
- Scott Gottlieb
- New York
A study of women using hormone replacement therapy after menopause found that the treatment does not increase the risk of highly malignant breast cancer but does raise the risk of some uncommonforms of the disease that are slow growing and highly treatable. Some previous studies have shown that women who take oestrogen after menopause are more likely to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial